Drugs for youth via Internet and the example of mephedrone
Recently a new class of “designer drugs” has emerged on the drugs abuse market, known as “legal highs”. Such drugs are legal to use and possess, and legal to supply. Mephedrone, a central nervous system stimulant, is the most widely experienced “legal high”. This review presents any available inform...
Saved in:
| Published in | Toxicology letters Vol. 201; no. 3; pp. 191 - 195 |
|---|---|
| Main Authors | , , |
| Format | Journal Article |
| Language | English |
| Published |
Shannon
Elsevier Ireland Ltd
25.03.2011
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Recently a new class of “designer drugs” has emerged on the drugs abuse market, known as “legal highs”. Such drugs are legal to use and possess, and legal to supply. Mephedrone, a central nervous system stimulant, is the most widely experienced “legal high”.
This review presents any available information about psychoactive properties, safety profile, clinical data, and legislation of the new “legal high” and emphasizes the role of Internet with mephedrone's expansion. Available data were collected by various literature search engines and World Wide Web. All valuable information about psychoactive properties, safety profile and clinical data for mephedrone and its use as “legal high” were managed to spot and summarise.
Internet plays a significant role for the distribution of “legal highs”, becoming one of the major “drug market”. Adolescents and young adults who are curious about drugs may search on the Internet and thereby become exposed to thousands of sites that expound upon the positive effects of drugs and downplay or deny any negative effects. Use of mephedrone is mainly a youth phenomenon. The hazardous side-effects are strong desire to re-dose, uncomfortable changes in body temperature and heart rate, hallucinations and psychosis. |
|---|---|
| AbstractList | Recently a new class of “designer drugs” has emerged on the drugs abuse market, known as “legal highs”. Such drugs are legal to use and possess, and legal to supply. Mephedrone, a central nervous system stimulant, is the most widely experienced “legal high”.
This review presents any available information about psychoactive properties, safety profile, clinical data, and legislation of the new “legal high” and emphasizes the role of Internet with mephedrone's expansion. Available data were collected by various literature search engines and World Wide Web. All valuable information about psychoactive properties, safety profile and clinical data for mephedrone and its use as “legal high” were managed to spot and summarise.
Internet plays a significant role for the distribution of “legal highs”, becoming one of the major “drug market”. Adolescents and young adults who are curious about drugs may search on the Internet and thereby become exposed to thousands of sites that expound upon the positive effects of drugs and downplay or deny any negative effects. Use of mephedrone is mainly a youth phenomenon. The hazardous side-effects are strong desire to re-dose, uncomfortable changes in body temperature and heart rate, hallucinations and psychosis. Recently a new class of "designer drugs" has emerged on the drugs abuse market, known as "legal highs". Such drugs are legal to use and possess, and legal to supply. Mephedrone, a central nervous system stimulant, is the most widely experienced "legal high". This review presents any available information about psychoactive properties, safety profile, clinical data, and legislation of the new "legal high" and emphasizes the role of Internet with mephedrone's expansion. Available data were collected by various literature search engines and World Wide Web. All valuable information about psychoactive properties, safety profile and clinical data for mephedrone and its use as "legal high" were managed to spot and summarise. Internet plays a significant role for the distribution of "legal highs", becoming one of the major "drug market". Adolescents and young adults who are curious about drugs may search on the Internet and thereby become exposed to thousands of sites that expound upon the positive effects of drugs and downplay or deny any negative effects. Use of mephedrone is mainly a youth phenomenon. The hazardous side-effects are strong desire to re-dose, uncomfortable changes in body temperature and heart rate, hallucinations and psychosis. |
| Author | Pistos, C. Vardakou, I. Spiliopoulou, Ch |
| Author_xml | – sequence: 1 givenname: I. surname: Vardakou fullname: Vardakou, I. – sequence: 2 givenname: C. surname: Pistos fullname: Pistos, C. email: cpistos@med.uoa.gr – sequence: 3 givenname: Ch surname: Spiliopoulou fullname: Spiliopoulou, Ch |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23924202$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/21187132$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kMtKAzEUhoNUtK2-gUg24mpqbp3MuBDEOwhudB0ykxM7ZWZSk4zUtzelVXeuDhy-_1y-CRr1rgeETiiZUULzi-UsunULccbIpsVmhIo9NKaFLDNO83KExoTLIhNMikM0CWFJCMlFPj9Ah4wmjHI2Rpe3fngP2DqPv9wQF_iz0fipj-B7iFj3BscFYFjrbtUCdhZ3sFqA8emWI7RvdRvgeFen6O3-7vXmMXt-eXi6uX7OasF4zIShtCoLPc8p4SUHYmwlpDRCWlrNRZ5zTkpWlYZROTeFKRi3hYZKCpl4Y_kUnW_nrrz7GCBE1TWhhrbVPbghqCIvC0bTl4kUW7L2LgQPVq1802n_pShRG2lqqbbS1EaaokwlaSl2ulswVB2Y39CPpQSc7QAdat1ar_u6CX8cL5lgZMNdbTlIOj4b8CrUDfQ1mMZDHZVxzf-XfAOsqIyB |
| CODEN | TOLED5 |
| CitedBy_id | crossref_primary_10_1016_j_brainresbull_2016_03_005 crossref_primary_10_1136_bmjopen_2012_000977 crossref_primary_10_1007_s11469_023_01195_8 crossref_primary_10_1016_j_scijus_2013_08_004 crossref_primary_10_1016_j_toxlet_2014_06_012 crossref_primary_10_1007_s12103_013_9221_7 crossref_primary_10_1093_chromsci_bms183 crossref_primary_10_1016_j_forsciint_2013_08_021 crossref_primary_10_4155_bio_14_31 crossref_primary_10_1002_dta_1789 crossref_primary_10_1016_j_pediatrneurol_2014_03_003 crossref_primary_10_1097_PEC_0b013e318233ed26 crossref_primary_10_3109_01480545_2011_642381 crossref_primary_10_1002_hup_2466 crossref_primary_10_1021_ac302542r crossref_primary_10_1016_j_jpba_2013_03_016 crossref_primary_10_3310_phr05040 crossref_primary_10_1080_17523281_2012_679293 crossref_primary_10_1080_15504263_2012_697447 crossref_primary_10_1186_s13722_015_0024_7 crossref_primary_10_1007_s12103_014_9270_6 crossref_primary_10_1016_j_forsciint_2013_04_015 crossref_primary_10_1007_BF03405642 crossref_primary_10_1177_0269881115598415 crossref_primary_10_1177_0269881116653106 crossref_primary_10_1080_02791072_2013_803647 crossref_primary_10_1016_j_toxlet_2014_06_020 crossref_primary_10_3389_fphar_2021_679759 crossref_primary_10_1016_j_neuropharm_2014_07_004 crossref_primary_10_1007_s11469_022_00988_7 crossref_primary_10_1111_ppc_12101 crossref_primary_10_1111_j_1476_5381_2012_02236_x crossref_primary_10_1177_0022042619826079 crossref_primary_10_1371_journal_pone_0099002 crossref_primary_10_1016_j_ejphar_2013_05_024 crossref_primary_10_1016_j_drugpo_2016_03_007 crossref_primary_10_1016_j_toxlet_2011_10_010 crossref_primary_10_1093_qjmed_hcv171 crossref_primary_10_1016_j_pnpbp_2014_04_009 crossref_primary_10_1111_bph_13030 crossref_primary_10_1016_j_pnpbp_2013_04_007 crossref_primary_10_1093_ijnp_pyu106 crossref_primary_10_1007_s00044_011_9794_y crossref_primary_10_1002_dta_1369 crossref_primary_10_17795_jjnpp_9990 crossref_primary_10_1111_bph_13547 crossref_primary_10_1080_00498254_2017_1401753 crossref_primary_10_3109_00952990_2011_643999 crossref_primary_10_3389_fphar_2019_01588 crossref_primary_10_1007_s11419_017_0385_6 crossref_primary_10_1111_j_1476_5381_2012_01998_x crossref_primary_10_3390_molecules26206143 crossref_primary_10_1016_j_drugpo_2012_01_008 crossref_primary_10_1186_1747_597X_6_20 crossref_primary_10_3109_09687637_2011_617796 crossref_primary_10_1108_17459261111174046 crossref_primary_10_1080_09502386_2018_1435702 crossref_primary_10_5402_2012_838432 crossref_primary_10_1111_bph_13813 crossref_primary_10_1007_s11419_015_0263_z crossref_primary_10_1556_OH_2014_29955 crossref_primary_10_1080_03602532_2016_1188937 crossref_primary_10_1039_C4AY02169J crossref_primary_10_1177_0269881114548439 crossref_primary_10_1007_s12640_019_00020_2 crossref_primary_10_1155_2014_209875 crossref_primary_10_1016_j_amjmed_2012_02_019 crossref_primary_10_3109_14659891_2014_895872 crossref_primary_10_1002_hup_2307 crossref_primary_10_1016_j_ntt_2021_106977 crossref_primary_10_1007_s00204_013_1163_9 crossref_primary_10_1016_j_legalmed_2011_02_003 crossref_primary_10_1016_j_drugpo_2016_01_011 crossref_primary_10_1080_01639625_2014_977114 crossref_primary_10_1097_FBP_0b013e3283641ec8 crossref_primary_10_1016_j_forsciint_2012_04_034 crossref_primary_10_3109_00365513_2013_793817 crossref_primary_10_1111_j_1749_6632_2011_06199_x crossref_primary_10_3109_09687637_2013_769500 crossref_primary_10_3389_fpsyt_2017_00152 crossref_primary_10_1097_NUR_0b013e318229963f crossref_primary_10_1007_s00213_013_3223_5 crossref_primary_10_1038_npp_2016_75 crossref_primary_10_1002_dta_1633 crossref_primary_10_1016_j_ajp_2016_01_014 crossref_primary_10_1016_j_drugpo_2013_01_005 crossref_primary_10_1080_09687637_2016_1275526 crossref_primary_10_1111_bph_12628 crossref_primary_10_23907_2012_037 crossref_primary_10_1177_1741659013511975 crossref_primary_10_1016_j_jpba_2012_09_019 crossref_primary_10_4155_fmc_11_186 crossref_primary_10_1024_0939_5911_a000230 crossref_primary_10_3389_fnins_2019_00124 crossref_primary_10_1016_j_scijus_2012_10_002 crossref_primary_10_1093_jat_bks049 crossref_primary_10_3390_ijms23042122 crossref_primary_10_1016_j_taap_2015_12_019 crossref_primary_10_1038_nrneph_2014_44 crossref_primary_10_1111_j_1369_1600_2012_00474_x crossref_primary_10_1016_j_forsciint_2014_01_018 crossref_primary_10_1007_s11419_015_0295_4 crossref_primary_10_1016_j_pbb_2012_10_006 crossref_primary_10_1016_j_ejphar_2012_11_008 crossref_primary_10_1016_j_taap_2015_03_015 crossref_primary_10_1177_0011392115596055 crossref_primary_10_1108_17459261211286654 crossref_primary_10_1016_j_pnpbp_2013_08_013 crossref_primary_10_1016_S0377_4732_11_70067_0 crossref_primary_10_2478_cipms_2023_0011 crossref_primary_10_3109_15563650_2012_729667 crossref_primary_10_1016_j_drudis_2014_09_021 crossref_primary_10_1080_02791072_2014_934979 crossref_primary_10_1016_j_toxlet_2012_04_019 crossref_primary_10_1002_dta_1615 crossref_primary_10_1016_j_jpba_2011_11_026 crossref_primary_10_1007_s11419_015_0287_4 crossref_primary_10_1016_j_pharep_2018_05_010 crossref_primary_10_1007_s11419_018_0417_x crossref_primary_10_1038_npp_2011_304 |
| Cites_doi | 10.1093/qjmed/hcq056 10.1093/jat/34.3.162 10.1016/j.toxlet.2010.03.081 10.1016/S0140-6736(10)60559-4 10.5042/daat.2010.0251 10.1016/S0140-6736(10)60556-9 10.1007/s00431-008-0811-1 10.1136/bmj.c1605 10.1136/bmj.c1690 10.1007/s00216-010-3636-5 10.1016/j.toxlet.2010.06.002 10.1016/j.forsciint.2009.12.048 10.1007/s13181-010-0018-5 |
| ContentType | Journal Article |
| Copyright | 2010 Elsevier Ireland Ltd 2015 INIST-CNRS Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
| Copyright_xml | – notice: 2010 Elsevier Ireland Ltd – notice: 2015 INIST-CNRS – notice: Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
| DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7U7 C1K |
| DOI | 10.1016/j.toxlet.2010.12.014 |
| DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Toxicology Abstracts Environmental Sciences and Pollution Management |
| DatabaseTitleList | MEDLINE Toxicology Abstracts |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1879-3169 |
| EndPage | 195 |
| ExternalDocumentID | 10_1016_j_toxlet_2010_12_014 21187132 23924202 S0378427410018023 |
| Genre | Journal Article Review Case Reports |
| GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFRF ABFYP ABJNI ABLST ABMAC ABXDB ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AKIFW ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BLECG BLXMC CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU G-Q GBLVA HZ~ IHE J1W KCYFY KOM M34 M41 MO0 N9A O-L O9- OAUVE OGGZJ OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SDP SES SPCBC SSJ SSP SSZ T5K WH7 ~G- ~KM .GJ 29Q 53G AAQXK AATCM ABEFU ABFNM ABPIF ABPTK AFFNX AGHFR AHEUO AJOXV ASPBG AVWKF AZFZN BKOJK FEDTE FGOYB FYGXN G-2 HMT IQODW R2- SEW SPT WUQ XPP ZGI ZXP AKRWK CGR CUY CVF ECM EIF NPM AAXKI AAYXX ACRPL ADNMO AFJKZ CITATION HVGLF 7U7 C1K |
| ID | FETCH-LOGICAL-c423t-4d11b98a5610393e0dfb477d47f1b546633092b9d2175d8d823f8aeb747039df3 |
| IEDL.DBID | .~1 |
| ISSN | 0378-4274 |
| IngestDate | Fri Aug 16 05:28:23 EDT 2024 Fri Dec 06 05:17:53 EST 2024 Sat Sep 28 07:56:32 EDT 2024 Sun Oct 22 16:03:14 EDT 2023 Fri Feb 23 02:14:38 EST 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Keywords | Mephedrone Youth Legal highs Internet Adolescents Designer drugs Human Drug Legislation Adolescent |
| Language | English |
| License | CC BY 4.0 Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. https://www.elsevier.com/tdm/userlicense/1.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c423t-4d11b98a5610393e0dfb477d47f1b546633092b9d2175d8d823f8aeb747039df3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 21187132 |
| PQID | 869821274 |
| PQPubID | 23462 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_869821274 crossref_primary_10_1016_j_toxlet_2010_12_014 pubmed_primary_21187132 pascalfrancis_primary_23924202 elsevier_sciencedirect_doi_10_1016_j_toxlet_2010_12_014 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-03-25 |
| PublicationDateYYYYMMDD | 2011-03-25 |
| PublicationDate_xml | – month: 03 year: 2011 text: 2011-03-25 day: 25 |
| PublicationDecade | 2010 |
| PublicationPlace | Shannon |
| PublicationPlace_xml | – name: Shannon – name: Netherlands |
| PublicationTitle | Toxicology letters |
| PublicationTitleAlternate | Toxicol Lett |
| PublicationYear | 2011 |
| Publisher | Elsevier Ireland Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ireland Ltd – name: Elsevier |
| References | Tsitsika, Critselis, Kormas, Filippopoulou, Tounissidou, Freskou, Spiliopoulou, Louizou, Konstantoulaki, Kafetzis (bib0160) 2009; 168 (accessed: 17 Jan 2011). Linell, M., 2010. Case study. Use of mephedrone in a Northern Town. The Lifeline project. Oral evidence to the ACMD. The Local: teenager dies of “net drug” overdose. The Local: Sweden's News in English. Retrieved from EMCDDA–Europol, 2009. On the implementation of Council Decision 2005/387/JHA Annual Report. Shafer, J. Designer drugs. Magazine work. Retrieved from Johnson (bib0100) 2010; 375 EMCDDA, 2010c. On submitting 4-methylmethcathinone (mephedrone) to control measures. Council Decision. Dickson, Vorce, Levine, Past (bib0045) 2010; 34 McGuiness R., Girl killed by legal web drug meow meow. Retrieved from Morris (bib0125) 2010; 375 Eastwood (bib0060) 2010; 10 EMCDDA, 2003. Drugs in Focus: Drug use amongst vulnerable young people. Levy A., Teenager dies after experimenting with legal drug meow meow. Retrieved from (accessed 17 Jan 2011). Newcombe (bib0130) 2009 Psychonaut Web Mapping Research Group (2010). Mephedrone report. Wood, Davies, Puchnarewicz, Button, Archer, Ovaska, Ramsey, Lee, Holt, Dargan (bib0180) 2010 EMCDDA, 2010. Early worning system: summary findings: mephedrone. Europol–EMCDDA, 2010b. Joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Williams, M., Doctors call for ban on “legal high” after woman dies. Herald Scotland. Retrieved from Camilleri, Johnston, Brennan, Davis, Caldicott (bib0025) 2010; 197 Vardakou, Pistos, Spiliopoulou (bib0165) 2010; 197 Druglink, 2010. How mephedrone shook the drug trade. Winstock, Marsden, Mitcheson (bib0175) 2010; 340c Davies, Wood, Smith, Button, Ramsey, Archer, Holt, Dargan (bib0040) 2010; 103 Meyer, Wilhelm, Peters, Maurer (bib0120) 2010; 397 Campbell, D., Online sales of legal alternatives to class A drug raise safety fears. The Guardian. Retrieved from Gustavsson, Esher (bib0095) 2009; 106 Advisory Council on the Misuse of Drugs (ACMD), 2010. Consideration of the cathinones. Office of Public Sector Information (OPSI): The Misuse of Drugs (Amendment) (England, Wales and Scotland) Regulations. No. 1144 EMCDDA, 2010a. News release from the EU drugs agency in Lisbon. New drug placed under official scrutiny across Europe. Council calls on EU scientific experts to assess risks of mephedrone. Dyer (bib0055) 2010; 340 Bates, T. Owen J., Minister was told of explosion in “legal highs”. The Independent. Retrieved from Dargan, Wood (bib0035) 2010; 196 10.1016/j.toxlet.2010.12.014_bib0090 Newcombe (10.1016/j.toxlet.2010.12.014_bib0130) 2009 10.1016/j.toxlet.2010.12.014_bib0050 Gustavsson (10.1016/j.toxlet.2010.12.014_bib0095) 2009; 106 Dyer (10.1016/j.toxlet.2010.12.014_bib0055) 2010; 340 10.1016/j.toxlet.2010.12.014_bib0150 10.1016/j.toxlet.2010.12.014_bib0070 10.1016/j.toxlet.2010.12.014_bib0170 Dickson (10.1016/j.toxlet.2010.12.014_bib0045) 2010; 34 Winstock (10.1016/j.toxlet.2010.12.014_bib0175) 2010; 340c Johnson (10.1016/j.toxlet.2010.12.014_bib0100) 2010; 375 10.1016/j.toxlet.2010.12.014_bib0005 Eastwood (10.1016/j.toxlet.2010.12.014_bib0060) 2010; 10 10.1016/j.toxlet.2010.12.014_bib0105 Camilleri (10.1016/j.toxlet.2010.12.014_bib0025) 2010; 197 10.1016/j.toxlet.2010.12.014_bib0065 10.1016/j.toxlet.2010.12.014_bib0085 10.1016/j.toxlet.2010.12.014_bib0140 10.1016/j.toxlet.2010.12.014_bib0185 10.1016/j.toxlet.2010.12.014_bib0020 Morris (10.1016/j.toxlet.2010.12.014_bib0125) 2010; 375 Meyer (10.1016/j.toxlet.2010.12.014_bib0120) 2010; 397 10.1016/j.toxlet.2010.12.014_bib0145 10.1016/j.toxlet.2010.12.014_bib0080 Wood (10.1016/j.toxlet.2010.12.014_bib0180) 2010 Davies (10.1016/j.toxlet.2010.12.014_bib0040) 2010; 103 10.1016/j.toxlet.2010.12.014_bib0115 Tsitsika (10.1016/j.toxlet.2010.12.014_bib0160) 2009; 168 10.1016/j.toxlet.2010.12.014_bib0110 10.1016/j.toxlet.2010.12.014_bib0030 10.1016/j.toxlet.2010.12.014_bib0075 Dargan (10.1016/j.toxlet.2010.12.014_bib0035) 2010; 196 10.1016/j.toxlet.2010.12.014_bib0135 Vardakou (10.1016/j.toxlet.2010.12.014_bib0165) 2010; 197 10.1016/j.toxlet.2010.12.014_bib0155 |
| References_xml | – volume: 197 start-page: 157 year: 2010 end-page: 162 ident: bib0165 article-title: Spice drugs as a new trend: mode of action, identification and legislation publication-title: Toxicology Letters contributor: fullname: Spiliopoulou – volume: 34 start-page: 162 year: 2010 end-page: 168 ident: bib0045 article-title: Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin publication-title: Journal of Analytical Toxicology contributor: fullname: Past – volume: 168 start-page: 655 year: 2009 end-page: 665 ident: bib0160 article-title: Internet use and misuse: a multivariate regression analysis of the predictive factors of Internet use among Greek adolescents publication-title: European Journal of Pediatrics contributor: fullname: Kafetzis – volume: 196 start-page: 16 year: 2010 ident: bib0035 article-title: Novel and emerging recreational drugs publication-title: Toxicology Letters contributor: fullname: Wood – volume: 103 start-page: 489 year: 2010 end-page: 493 ident: bib0040 article-title: Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? publication-title: Quarterly Journal of Medicine contributor: fullname: Dargan – volume: 375 start-page: 1319 year: 2010 ident: bib0100 article-title: A collapse in integrity of scientific advice in the UK publication-title: The Lancet contributor: fullname: Johnson – volume: 397 start-page: 1225 year: 2010 end-page: 1233 ident: bib0120 article-title: Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry publication-title: Analytical and Bioanalytical Chemistry contributor: fullname: Maurer – volume: 340 start-page: 1690 year: 2010 ident: bib0055 article-title: Mephedrone is an amphetamine “by another name” drug adviser tells MPs publication-title: British Medical Journal contributor: fullname: Dyer – year: 2010 ident: bib0180 article-title: Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity publication-title: Journal of Medicine Toxicology contributor: fullname: Dargan – volume: 197 start-page: 59 year: 2010 end-page: 66 ident: bib0025 article-title: Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, a-phthalimidopropiophenone and N-ethylcathinone publication-title: Forensic Science International contributor: fullname: Caldicott – volume: 106 start-page: 2769 year: 2009 end-page: 2771 ident: bib0095 article-title: Mefedrone-Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance publication-title: Lakartidningen contributor: fullname: Esher – volume: 10 start-page: 6 year: 2010 end-page: 9 ident: bib0060 article-title: Legal eye publication-title: Drugs and Alcohol Today contributor: fullname: Eastwood – volume: 340c start-page: 1605 year: 2010 ident: bib0175 article-title: What should be done about mephedrone? publication-title: British Medical Journal contributor: fullname: Mitcheson – year: 2009 ident: bib0130 article-title: The Use of Mephedrone (M-cat, Meow) in Middlesbrough contributor: fullname: Newcombe – volume: 375 start-page: 1333 year: 2010 end-page: 1334 ident: bib0125 article-title: UK places generic ban on mephedrone drug family publication-title: The Lancet contributor: fullname: Morris – ident: 10.1016/j.toxlet.2010.12.014_bib0150 – ident: 10.1016/j.toxlet.2010.12.014_bib0020 – ident: 10.1016/j.toxlet.2010.12.014_bib0070 – volume: 103 start-page: 489 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0040 article-title: Purchasing ‘legal highs’ on the Internet—is there consistency in what you get? publication-title: Quarterly Journal of Medicine doi: 10.1093/qjmed/hcq056 contributor: fullname: Davies – volume: 34 start-page: 162 issue: 3 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0045 article-title: Multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (mephedrone) and heroin publication-title: Journal of Analytical Toxicology doi: 10.1093/jat/34.3.162 contributor: fullname: Dickson – volume: 196 start-page: 16 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0035 article-title: Novel and emerging recreational drugs publication-title: Toxicology Letters doi: 10.1016/j.toxlet.2010.03.081 contributor: fullname: Dargan – ident: 10.1016/j.toxlet.2010.12.014_bib0085 – ident: 10.1016/j.toxlet.2010.12.014_bib0140 – ident: 10.1016/j.toxlet.2010.12.014_bib0005 – ident: 10.1016/j.toxlet.2010.12.014_bib0030 – ident: 10.1016/j.toxlet.2010.12.014_bib0135 – ident: 10.1016/j.toxlet.2010.12.014_bib0185 – volume: 375 start-page: 1333 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0125 article-title: UK places generic ban on mephedrone drug family publication-title: The Lancet doi: 10.1016/S0140-6736(10)60559-4 contributor: fullname: Morris – volume: 106 start-page: 2769 year: 2009 ident: 10.1016/j.toxlet.2010.12.014_bib0095 article-title: Mefedrone-Internet drug which seems to have come and stay. Fatal cases in Sweden have drawn attention to previously unknown substance publication-title: Lakartidningen contributor: fullname: Gustavsson – ident: 10.1016/j.toxlet.2010.12.014_bib0110 – ident: 10.1016/j.toxlet.2010.12.014_bib0065 – ident: 10.1016/j.toxlet.2010.12.014_bib0090 – volume: 10 start-page: 6 issue: 2 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0060 article-title: Legal eye publication-title: Drugs and Alcohol Today doi: 10.5042/daat.2010.0251 contributor: fullname: Eastwood – volume: 375 start-page: 1319 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0100 article-title: A collapse in integrity of scientific advice in the UK publication-title: The Lancet doi: 10.1016/S0140-6736(10)60556-9 contributor: fullname: Johnson – ident: 10.1016/j.toxlet.2010.12.014_bib0145 – volume: 168 start-page: 655 year: 2009 ident: 10.1016/j.toxlet.2010.12.014_bib0160 article-title: Internet use and misuse: a multivariate regression analysis of the predictive factors of Internet use among Greek adolescents publication-title: European Journal of Pediatrics doi: 10.1007/s00431-008-0811-1 contributor: fullname: Tsitsika – volume: 340c start-page: 1605 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0175 article-title: What should be done about mephedrone? publication-title: British Medical Journal doi: 10.1136/bmj.c1605 contributor: fullname: Winstock – volume: 340 start-page: 1690 issue: c year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0055 article-title: Mephedrone is an amphetamine “by another name” drug adviser tells MPs publication-title: British Medical Journal doi: 10.1136/bmj.c1690 contributor: fullname: Dyer – ident: 10.1016/j.toxlet.2010.12.014_bib0105 – volume: 397 start-page: 1225 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0120 article-title: Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography–mass spectrometry publication-title: Analytical and Bioanalytical Chemistry doi: 10.1007/s00216-010-3636-5 contributor: fullname: Meyer – year: 2009 ident: 10.1016/j.toxlet.2010.12.014_bib0130 contributor: fullname: Newcombe – ident: 10.1016/j.toxlet.2010.12.014_bib0080 – volume: 197 start-page: 157 issue: 3 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0165 article-title: Spice drugs as a new trend: mode of action, identification and legislation publication-title: Toxicology Letters doi: 10.1016/j.toxlet.2010.06.002 contributor: fullname: Vardakou – ident: 10.1016/j.toxlet.2010.12.014_bib0050 – volume: 197 start-page: 59 year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0025 article-title: Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, a-phthalimidopropiophenone and N-ethylcathinone publication-title: Forensic Science International doi: 10.1016/j.forsciint.2009.12.048 contributor: fullname: Camilleri – year: 2010 ident: 10.1016/j.toxlet.2010.12.014_bib0180 article-title: Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity publication-title: Journal of Medicine Toxicology doi: 10.1007/s13181-010-0018-5 contributor: fullname: Wood – ident: 10.1016/j.toxlet.2010.12.014_bib0155 – ident: 10.1016/j.toxlet.2010.12.014_bib0170 – ident: 10.1016/j.toxlet.2010.12.014_bib0075 – ident: 10.1016/j.toxlet.2010.12.014_bib0115 |
| SSID | ssj0006465 |
| Score | 2.4403641 |
| SecondaryResourceType | review_article |
| Snippet | Recently a new class of “designer drugs” has emerged on the drugs abuse market, known as “legal highs”. Such drugs are legal to use and possess, and legal to... Recently a new class of "designer drugs" has emerged on the drugs abuse market, known as "legal highs". Such drugs are legal to use and possess, and legal to... |
| SourceID | proquest crossref pubmed pascalfrancis elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 191 |
| SubjectTerms | Adolescent Adolescents Animals Biological and medical sciences Central Nervous System Stimulants - poisoning Designer Drugs Humans Internet Legal highs Legislation, Drug Medical sciences Mephedrone Methamphetamine - analogs & derivatives Methamphetamine - poisoning Rats Substance-Related Disorders - epidemiology Toxicology Youth |
| Title | Drugs for youth via Internet and the example of mephedrone |
| URI | https://dx.doi.org/10.1016/j.toxlet.2010.12.014 https://www.ncbi.nlm.nih.gov/pubmed/21187132 https://search.proquest.com/docview/869821274 |
| Volume | 201 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhuRRCadNXmmbRoeQUdWU9_MgtpA3bloZAE8hNSJZUNlDvsust2Ut-e2Ysu0sOodCrkWQxI898Gs_MR8hHHiuthQ0s1zIwcAEFs5m0LPcuOvCXPq-xOPnHRT65Vt9u9M0WORtqYTCtsrf9yaZ31rp_Mu6lOZ5Pp-OfXBalwu4rSCwHrgcr2DVHFoNP95s0j1x1dJI4mOHooXyuy_FqZ3cgnZTghUHBTD3lnnbndglCi4nt4mk42rml8xfkeY8n6Wna8kuyFZo9cnSZGlKvj-nVpr5qeUyP6OWmVfV6j-ymqB1NxUivyMnnxerXkgKQpWvk1qN_ppamoGFoqW08BbxIw53FnsJ0FulvzBHzi1kTXpPr8y9XZxPWsyuwGiBUy5TPMleVFgGUrGTgPjpVFF4VMXNaARKRvBKu8nBp0b70pZCxtMHB_QPG-yjfkO0Gln9HaG0zx6OIZQ0SrHNeec5D1A7gVSWVF_uEDUI189REwwzZZbcmKcGgEkwmDCyxT4pB8ubRYTBg5_8xc_RIUX9fJwAHKsFhK3TQnIEPCf-O2CbMVktT5lWJ7e5hjbdJo5vJyMkO1_b3_72vA_IsBaMlE_oD2W4Xq3AIaKZ1o-64jsjO6dfvk4sHPpzylQ |
| link.rule.ids | 314,780,784,4502,24116,27924,27925,45585,45679 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcgCpQlAeLY_iA-qpZh0_8uCGCtUCbVWJrdSbZcc2WiSyq91s1b3w2xnHCaseKiSu0dgZzTgznyfzAHjHQqUUN57mSniKLqCgJhOG5s4Gi_7S5XUsTj47z8eX8uuVutqC46EWJqZV9rY_2fTOWvdPRr00R_PpdPSdiaKUsftKHCyHruce3JcK0S8e6ve_N3keuezmSUZqGsmH-rkuyaud3aB4UoZXjApm8i7_tDM3S5RaSOMu7sajnV86eQyPekBJPiaen8CWb3bh8CJ1pF4fkcmmwGp5RA7JxaZX9XoXdlLYjqRqpKfw4dNi9WNJEMmSdRyuR66nhqSooW-JaRxBwEj8jYlNhckskF8xScwtZo1_BpcnnyfHY9qPV6A1YqiWSpdltipNRFCiEp65YGVROFmEzCqJUESwitvK4a1FudKVXITSeIsXEKR3QTyH7Qa33wNSm8yywENZowTrnFWOMR-URXxVCen4PtBBqHqeumjoIb3sp05K0FEJOuMat9iHYpC8vnUaNBr6f6w8uKWov6_jCAQlZ8gKGTSn8UuKv0dM42erpS7zqoz97nGPF0mjm8VxKDve21_-N19v4cF4cnaqT7-cf3sFD1NkWlCuXsN2u1j5NwhtWnvQHd0_9hH0Mg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Drugs+for+youth+via+Internet+and+the+example+of+mephedrone&rft.jtitle=Toxicology+letters&rft.au=Vardakou%2C+I&rft.au=Pistos%2C+C&rft.au=Spiliopoulou%2C+Ch&rft.date=2011-03-25&rft.issn=0378-4274&rft.volume=201&rft.issue=3&rft.spage=191&rft.epage=195&rft_id=info:doi/10.1016%2Fj.toxlet.2010.12.014&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-4274&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-4274&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-4274&client=summon |